Location of Repository

Non-beta-cell progenitors in pregnant mice and the origin and functionality of beta-cells after diabetic recovery in a c-Myc ablation model

By Sylvie Abouna

Abstract

The debate regarding the contribution of adult stem/progenitor cells during normal growth and beta-cell regeneration is far from being resolved. Therefore, we addressed in two distinct situations the origin of new beta-cells. We exploited a Cre/loxP lineage tracing system to efficiently label beta-cells in double transgenic mice (Z/AP; RIPCreERTAM) to address the origin of new beta-cell during the beta-cell mass expansion in response to one and two pregnancies. Similarly, we examined origin of new beta-cell after diabetic recovery in triple transgenic mouse (Z/AP; RIPCreERTAM; pIns-c-MycERTAM). Finally we evaluated the functionality of regenerated beta-cells after diabetic recovery in the single pIns-c-MycERTAM mouse model by microfluorimetry, in collaboration with Dr P. Squires. We showed that the beta-cell functionality in the pIns-c-MycERTAM line was abnormal. Second, we showed that the human placental alkaline phosphatase label (HPAP) in the double and triple transgenic mice was 1) specific to beta-cells, 2) irreversible and heritable and 3) tamoxifen dose-dependant. Third, the analysis of the proportion of beta-cells labelled for HPAP in one pregnancy, showed that the HPAP labelling index of the non-pregnant animals (0.44±0.05) was greater that in the pregnant group (0.33±0.06),(paired two-tailed t-test, P-value 0.021), indicating a dilution of the label in pregnant animal pancreata. Furthermore the combined results of the mean HPAP labelling index in non-pregnant animals (0.44±0.12) and pregnant animals (0.33±0.09) in one and two pregnancies reinforced our results above by indicating that the difference between the two groups was considered extremely significant (paired, two-sided student t-test, P-value 0.0007). Likewise, we showed that two to three months after the tamoxifen pulse, beta-cells do not fully lose differentiation or transdifferentiate into other lineages of either endocrine or exocrine compartment. In conclusion, we demonstrated for the first time that non-beta-cell progenitors contribute significantly to the increase of the beta-cell mass in response to pregnancy in combination with pre-existing beta-cell self-duplication

Topics: QH426
OAI identifier: oai:wrap.warwick.ac.uk:3107

Suggested articles

Preview

Citations

  1. (2007). A multipotent progenitor domain guides pancreatic organogenesis. doi
  2. (2008). Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. doi
  3. (2009). Can pancreatic duct-derived progenitors be a source of islet regeneration? doi
  4. (2007). Differentiation of affinity-purified human pancreatic duct cells to betacells. doi
  5. (2007). Essential role of Skp2-mediated p27 degradation in growth and adaptive expansion of pancreatic beta cells. doi
  6. (2005). Identification and expansion of pancreatic stem/progenitor cells. doi
  7. (2008). In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. doi
  8. (2001). Multipotential nestinpositive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. doi
  9. (2005). Overexpression of cyclin D1 in pancreatic beta-cells in vivo results in islet hyperplasia without hypoglycemia. doi
  10. (1997). Proliferation and differentiation of pancreatic beta-cells: ultrastructural analysis of the pancreas in diabetic mice induced by selective alloxan perfusion. doi
  11. (2000). Recombinant human betacellulin promotes the neogenesis of beta-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusion. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.